aprindine has been researched along with Myocarditis in 1 studies
Aprindine: A class Ib anti-arrhythmia agent used to manage ventricular and supraventricular arrhythmias.
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Niederberger, M | 1 |
Gasic, S | 1 |
Haber, P | 1 |
1 other study available for aprindine and Myocarditis
Article | Year |
---|---|
[Proceedings: Effect of aprindine on extrasystole and hemodynamics in an exertion study].
Topics: Adolescent; Adult; Aged; Aprindine; Cardiac Complexes, Premature; Coronary Disease; Heart Rate; Hemo | 1975 |